Founded in 1975, ICRF is a charitable organization that funds innovative studies by Israeli scientists. With over $48 million provided, ICRF selects awardees through a rigorous peer-review process. Their support has led to advancements in chemotherapies, bone marrow transplantation techniques, and tumor suppressor gene understanding. ICRF grants are given to cancer researchers in scientific research institutions, universities, and hospitals.